Silica-Based Nanoparticles And Methods Of Stimulating Bone Formation And Suppressing Bone Resorption Through Modulation Of Nf-Kb


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

WEITZMANN MERVYN NEALE , BECK GEORGE RICHARD , LEE JIN-KYU

ABSTRACT

Osteoporosis, is an exceedingly common malady that leads to bone fracture and results from an imbalance in the rate of osteoblastic bone formation with respect to osteoclastic bone degradation. Nanotechnology has raised exciting possibilities for the development of novel therapeutic agents. Embodiments of the disclosure provide silica- based fluorescent nanoparticles endowed with natural bone targeting capabilities and expressing potent pro-osteoblastogenic and concomitant anti-osteoclastogenic activities in vitro and the capacity to increase bone mineral density in vivo. Embodiments of the discosure can achieve their stimulatory effects on osteoblasts, and inhibitory effects on osteoclasts, in part by suppressing NF-ϰB signal transduction. Embodiments of the present disclosure provide for derivatives of silica-based nanoparticles that represent a novel class of dual anti-catabolic and pro-anabolic agents that may be applicable to the amelioration of numerous osteoporotic conditions. More... »

Related SciGraph Publications

  • 2007-03. Preliminary investigation of bioactivity of nano biocomposite in JOURNAL OF MATERIALS SCIENCE: MATERIALS IN MEDICINE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "name": "WEITZMANN MERVYN NEALE", 
            "type": "Person"
          }, 
          {
            "name": "BECK GEORGE RICHARD", 
            "type": "Person"
          }, 
          {
            "name": "LEE JIN-KYU", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s10856-007-2014-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047353497", 
              "https://doi.org/10.1007/s10856-007-2014-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10856-007-2014-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047353497", 
              "https://doi.org/10.1007/s10856-007-2014-0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "description": "

    Osteoporosis, is an exceedingly common malady that leads to bone fracture and results from an imbalance in the rate of osteoblastic bone formation with respect to osteoclastic bone degradation. Nanotechnology has raised exciting possibilities for the development of novel therapeutic agents. Embodiments of the disclosure provide silica- based fluorescent nanoparticles endowed with natural bone targeting capabilities and expressing potent pro-osteoblastogenic and concomitant anti-osteoclastogenic activities in vitro and the capacity to increase bone mineral density in vivo. Embodiments of the discosure can achieve their stimulatory effects on osteoblasts, and inhibitory effects on osteoclasts, in part by suppressing NF-ϰB signal transduction. Embodiments of the present disclosure provide for derivatives of silica-based nanoparticles that represent a novel class of dual anti-catabolic and pro-anabolic agents that may be applicable to the amelioration of numerous osteoporotic conditions.

    ", "id": "sg:patent.EP-2185161-A4", "keywords": [ "bone resorption", "NF-kappa B", "osteoporosis", "malady", "bone fracture", "imbalance", "osteoblastic bone formation", "respect", "bone degradation", "nanotechnology", "exciting possibility", "development", "novel therapeutic agent", "embodiment", "disclosure", "fluorescent nanoparticles", "natural bone", "capability", "pro", "vitro", "capacity", "mineral", "vivo", "stimulatory effect", "osteoblast", "inhibitory effect", "osteoclast", "signal transduction", "derivative", "nanoparticles", "novel class", "Anabolic Agent", "amelioration", "condition" ], "name": "SILICA-BASED NANOPARTICLES AND METHODS OF STIMULATING BONE FORMATION AND SUPPRESSING BONE RESORPTION THROUGH MODULATION OF NF-KB", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.189967.8", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/EP-2185161-A4" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:30", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_0782263a.jsonl", "type": "Patent" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.EP-2185161-A4'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.EP-2185161-A4'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.EP-2185161-A4'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.EP-2185161-A4'


     

    This table displays all metadata directly associated to this object as RDF triples.

    67 TRIPLES      14 PREDICATES      48 URIs      41 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:patent.EP-2185161-A4 schema:about anzsrc-for:3053
    2 schema:author Nc61b75b78145480f90b7c1687fdfba86
    3 schema:citation sg:pub.10.1007/s10856-007-2014-0
    4 schema:description <p>Osteoporosis, is an exceedingly common malady that leads to bone fracture and results from an imbalance in the rate of osteoblastic bone formation with respect to osteoclastic bone degradation. Nanotechnology has raised exciting possibilities for the development of novel therapeutic agents. Embodiments of the disclosure provide silica- based fluorescent nanoparticles endowed with natural bone targeting capabilities and expressing potent pro-osteoblastogenic and concomitant anti-osteoclastogenic activities in vitro and the capacity to increase bone mineral density in vivo. Embodiments of the discosure can achieve their stimulatory effects on osteoblasts, and inhibitory effects on osteoclasts, in part by suppressing NF-&amp;kappav;B signal transduction. Embodiments of the present disclosure provide for derivatives of silica-based nanoparticles that represent a novel class of dual anti-catabolic and pro-anabolic agents that may be applicable to the amelioration of numerous osteoporotic conditions.</p>
    5 schema:keywords Anabolic Agent
    6 NF-kappa B
    7 amelioration
    8 bone degradation
    9 bone fracture
    10 bone resorption
    11 capability
    12 capacity
    13 condition
    14 derivative
    15 development
    16 disclosure
    17 embodiment
    18 exciting possibility
    19 fluorescent nanoparticles
    20 imbalance
    21 inhibitory effect
    22 malady
    23 mineral
    24 nanoparticles
    25 nanotechnology
    26 natural bone
    27 novel class
    28 novel therapeutic agent
    29 osteoblast
    30 osteoblastic bone formation
    31 osteoclast
    32 osteoporosis
    33 pro
    34 respect
    35 signal transduction
    36 stimulatory effect
    37 vitro
    38 vivo
    39 schema:name SILICA-BASED NANOPARTICLES AND METHODS OF STIMULATING BONE FORMATION AND SUPPRESSING BONE RESORPTION THROUGH MODULATION OF NF-KB
    40 schema:recipient https://www.grid.ac/institutes/grid.189967.8
    41 schema:sameAs https://app.dimensions.ai/details/patent/EP-2185161-A4
    42 schema:sdDatePublished 2019-03-07T15:30
    43 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    44 schema:sdPublisher N9b6f2a530ff047ce97679bbaff8b8a9c
    45 sgo:license sg:explorer/license/
    46 sgo:sdDataset patents
    47 rdf:type sgo:Patent
    48 N6119e2746db64533b167ee5db521b662 schema:name LEE JIN-KYU
    49 rdf:type schema:Person
    50 N7db57bbafb0747cd8c95a0227ade3ed1 schema:name BECK GEORGE RICHARD
    51 rdf:type schema:Person
    52 N9b6d6361cb684995b904ff1cb7d23d73 rdf:first N6119e2746db64533b167ee5db521b662
    53 rdf:rest rdf:nil
    54 N9b6f2a530ff047ce97679bbaff8b8a9c schema:name Springer Nature - SN SciGraph project
    55 rdf:type schema:Organization
    56 Nac5392063e754d1ab03c312f606a4062 schema:name WEITZMANN MERVYN NEALE
    57 rdf:type schema:Person
    58 Nc61b75b78145480f90b7c1687fdfba86 rdf:first Nac5392063e754d1ab03c312f606a4062
    59 rdf:rest Ncb10cbef6e5b4a71b4c54364e929fbcc
    60 Ncb10cbef6e5b4a71b4c54364e929fbcc rdf:first N7db57bbafb0747cd8c95a0227ade3ed1
    61 rdf:rest N9b6d6361cb684995b904ff1cb7d23d73
    62 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
    63 rdf:type schema:DefinedTerm
    64 sg:pub.10.1007/s10856-007-2014-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047353497
    65 https://doi.org/10.1007/s10856-007-2014-0
    66 rdf:type schema:CreativeWork
    67 https://www.grid.ac/institutes/grid.189967.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...